Tag: US market
MS US sales fall, single stocks gain ground
International | Products
05 Feb 2024 by Summer Wang
Sales of structured products in the US at Morgan Stanley dropped by 5.9% in 2023.
StructrPro: at-risk growth widens gap in the US, protected growth remains marginal
North America | Products
31 Jan 2024 by Tim Mortimer - FVC
In this article, we look at the market dynamics in the US around growth and income products over the last three years.
StructrPro: at-risk growth widens gap in the US, protected growth remains marginal
North America | Expert View
30 Jan 2024 by Tim Mortimer - FVC
In this article, we look at the market dynamics in the US around growth and income products over the last three years.
Spotlight on the US… good times ahead
North America | Products
05 Jan 2024 by SRP News
With the help of the StructrPro lifecycle management portal, we analysed the performance of the main issuers, underlyings and product types in the US market during Q4 2023.
Spotlight on… Uber joins the big time after rough ride
North America | Products
08 Dec 2023 by SRP News
We analysed the performance of structured products linked to the dial-a-ride company in the US market.
Best-selling products Americas 2023: Barclays' synthetic note reigns, fixed income callables leave their mark
International | Products
07 Dec 2023 by Summer Wang
SRP reviews the best-selling products in the US and Mexican markets in 2023.
GS structured note sales continue downward trend in US
International | Products
23 Nov 2023 by Summer Wang
Goldman Sachs (GS)’ sales of SEC-registered notes over the last nine months stands at less than half of 2022’s volume.
StructrPro: the risk of highly volatile underlyings cannot be underestimated
North America | Products
22 Nov 2023 by Suzi Hampson - FVC
We look at structured products in the US market linked to underlyings that have exhibited poor performance during 2023.
StructrPro: the risk of highly volatile underlyings cannot be underestimated
North America | Expert View
21 Nov 2023 by Suzi Hampson - FVC
We look at structured products in the US market linked to underlyings that have exhibited poor performance during 2023.